Discovery Laboratories says that Deerfield Management Company will provide the company up to $30 million in the form of a secured loan facility. Discovery Labs will use the money for development and commercialization of its Surfaxin lucinactant for the prevention of respiratory distress syndrome (RDS) in infants and Aerosurf aerosolized surfactant for the treatment of … [Read more...] about Discovery Labs gets $30 million for development of respiratory distress syndrome therapies
News
Critical reports positive results for intranasal growth hormone study
According to Critical Pharmaceuticals, a Phase 1b study has shown that its CP024 dry powder intranasal human growth hormone (hGH) was well tolerated with only a few minor adverse effects and showed a linear dose response. CP024 also induced production of therapeutic levels of insulin-like growth factor (IGF-1), making it the first nasal formulation of growth hormone … [Read more...] about Critical reports positive results for intranasal growth hormone study
MeadWestvaco expands preservative-free product manufacturing capacity
MeadWestvaco has announced a $7.5 million expansion of its pharmaceutical manufacturing Centre of Excellence in Hemer, Germany, an expansion the company attributes largely to growth in the preservative-free nasal product market. According to the company, the project includes additional capacity in clean room molding and assembly. MWV offers a number of spray pumps for … [Read more...] about MeadWestvaco expands preservative-free product manufacturing capacity
Prosonix names Cécile Miles as Chief Business Officer
Inhaled pharmaceutical company Prosonix has hired Cécile Miles as its Chief Business Officer. She had been Commercial Director, Europe for the Arrow Group, part of Watson (now Actavis) since May 2011. Prior to Arrow, she had worked in various capacities at Ark Therapeutics, PLIVA, Ranbaxy, and Fisons. Miles said, "I am very excited to be joining the Prosonix team … [Read more...] about Prosonix names Cécile Miles as Chief Business Officer
NEONC announces planned trial of intranasal therapy for brain cancer
California-based NEONC Technologies has announced plans for clinical trials of its NEO100 intranasal formulation of monoterpene perillyl alcohol (POH) for the treatment of gliomas and other CNS cancers. NEONC Chairman and CEO Thomas Chen, who is also Co-Director of the USC/Norris Neuro-Oncology Program and Professor of Neurological Surgery and Pathology at USC's Keck … [Read more...] about NEONC announces planned trial of intranasal therapy for brain cancer
Mystic gets US patent for intranasal delivery technology
The US Patent and Trade Office (USPTO) has granted Mystic Pharmaceuticals US Patent No. 8,377,009, according to the company. The patent, titled “Intranasal Cartridge Devices,” covers technology for a delivery system based on Mystic's unit dose delivery platforms for liquid or dry intranasal formulations of drugs and biologics. Mystic President and CEO Timothy … [Read more...] about Mystic gets US patent for intranasal delivery technology
Malvern Instruments offers particle characterization webinar series
Malvern Instruments has announced the launch of an Imaging Masterclass webinar series beginning February 26 and continuing throughout 2013. The company is also running a Laser Diffraction Masterclass series that covers wet and dry method development, optical property selection, and specification setting. According to the company, the initial session of the Imaging … [Read more...] about Malvern Instruments offers particle characterization webinar series
Pharmaxis gets financing for Bronchitol commercialization, negative recommendation from PADAC
According to Pharmaxis, the company has obtained up to $40 million from NovaQuest Pharma Opportunities Fund III for development, manufacturing, and commercialization of Bronchitol mannitol inhalation powder in the US and EU. At the same time, the company announced that Bronchitol had received a negative recommendation for the treatment of cystic fibrosis patients from … [Read more...] about Pharmaxis gets financing for Bronchitol commercialization, negative recommendation from PADAC
FDA issues warning to company for unapproved inhaler
The FDA and the US Federal Trade Commission (FTC) have issued a warning to a Florida company called Flu and Cold Defense LLC regarding its claims for an over-the-counter nasal vapor inhalation product called GermBullet. The warning cites claims such as, "[GermBullet] has been laboratory tested and shown to reduce illness-causing bacteria, cold and flu viruses and … [Read more...] about FDA issues warning to company for unapproved inhaler
Bend Research gets EU GMP certificate
The Swedish Medical Products Agency (MPA) has granted Bend Research a certificate of compliance with European Union good manufacturing practice (GMP) regulations for the company's manufacture and testing of clinical pharmaceutical supplies. All European health authorities recognize the MPA GMP certificate, as do agencies in some additional countries. Bend CEO Rod … [Read more...] about Bend Research gets EU GMP certificate